Review
Sep 2026
From insulin resistance to incretin receptor agonism in the prevention of type 2 diabetes mellitus in obese individuals.
Type 2 diabetes mellitus (T2DM) represents one of the most significant metabolic challenges of the modern era, with more than 828 million people worldwide living with diabetes. Obesity and insulin resistance are major modifiable contributors to T2DM risk and progression, although the disease is heterogeneous and arises...
B. Teofilović, Jelena Trkulja, N. Grujić-Letić et al.
· Current Medical Research and... · 0 citations